Price CloudO3GLOBAL COMMODITY MARKETS
English (US) Language
Human insulin 100 IU/mL icon
HEALTHCARE AND PHARMACEUTICALS · SOURCES REPORT DIFFERENT PRICE TYPES

Human Insulin 100 IU/mL Latest Prices

Human Insulin 100 IU/mL prices explained through U-100 concentration, regular and NPH formulations, vial or pen packs, and cold distribution.

Download history CSV ↓
Price series · 1

Price series — Human insulin 100 IU/mL

Sources report different price types Sources may update at different intervals

Exact item match: 0Related benchmark: 1Within recorded date window: 0Outside date range: 1No latest observation: 0Live reference: 0
Clear filters
Showing 1–1 of 1 Price seriesPage 1 / 1
Price series Human insulin 100 IU/mL
Provider / SourceCountry / market / CurrencyLatest priceObserved date / published periodFrequencyMappingStatusSource
NHSBSA England and WalesInsulin human 100 IU/mlHuman_insulin_isophane_biphasic_30_70|100units/ml|10ml_vial_human_isophane_biphasic_30_70|pack=1NHSBSA England and Wales GB · England and Wales NHS Drug TariffGBP / source pack 15.68GBP / source pack 10/1/20262026-10-01 – 2026-11-01 Government reimbursement referenceMonthly · Published period
Series detailsForm native: 10ml_vial_human_isophane_biphasic_30_70Ingredient: Human_insulin_isophane_biphasic_30_70Pack quantity native: 1Strength native: 100units/mlTariff category: CPublished price, not a recorded transactionOriginal currency and unitCoverage limited to the listed source and market
Related benchmark Outside date range Source ↗History

Price history

Each source has its own currency and unit · Sources may update at different intervals
No data in this range. View full history →

Historical price table

Actual publication periods; missing periods are not interpolated
0 records
Price history Human insulin 100 IU/mL — Each source has its own currency and unit
PeriodPrice (Each source has its own currency and unit)Source
No records in this range.

Definition: A recombinant human insulin medicine at a concentration of 100 international units per milliliter, also designated U-100.

Key Specifications and Terms:

Understanding Human insulin 100 IU/mL Prices

Plain pharmaceutical vials and an insulin delivery pen in a pharmacy cold-chain setting.
Illustrative image for the Human Insulin 100 IU/mL market guide.

Market Overview & Supply Chain Dynamics

Human Insulin 100 IU/mL is a recombinant biological medicine supplied at U-100 concentration. The concentration does not identify the formulation: regular insulin is a solution, while NPH is an isophane suspension. Biotechnology production, purification, sterile filling, cold chain management, and final presentation distinguish this market from ordinary tablet manufacturing. UK reimbursement references in pounds cover named packs, which may contain vials, cartridges, or pens.

Key Applications & Industrial Demand

Diabetes treatment programs purchase human insulin through hospitals, pharmacies, and public health tenders. Demand includes both continuing outpatient supply and institutional stock requirements. Procurement must identify formulation and delivery format because a vial, cartridge, and disposable pen impose different device, packaging, and distribution requirements.

Key Factors Influencing Human Insulin 100 IU/mL Price Movements

  • Biological Production and Sterility: Fermentation, purification, sterile filling, and biological batch-release capacity influence availability and manufacturing expense for recombinant insulin rather than chemical tablet-compression economics.
  • Formulation and Delivery Format: Regular insulin, NPH, and mixtures require distinct specifications; cartridges and prefilled pens add packaging and device components absent from a conventional vial.
  • Temperature-Controlled Distribution: Cold chain integrity, validated shipping, expiry management, and product-specific storage instructions affect usable inventory, especially where delivery networks are long or unreliable.

How to Interpret Human Insulin 100 IU/mL Pricing Data

Compare pounds per complete pack alongside total milliliters and total labeled units. A U-100 concentration does not make regular insulin, NPH, or a premixed presentation economically interchangeable. Pack costs may also include a pen device; needles, dispensing fees, and cold delivery can be charged separately from the insulin itself.

Further reading: DailyMed: Human Insulin U-100 Formulation and Packaging

Frequently Asked Questions About Human insulin 100 IU/mL

What Drives Price Changes for Human Insulin 100 IU/mL?

Biological production capacity, tender negotiations, presentation changes, and temperature-controlled distribution affect insulin costs. Public reimbursement and negotiated purchasing can move differently from pharmacy cash prices.

How Do Quality or Specification Differences Affect Human Insulin 100 IU/mL Pricing?

Identify regular, NPH, or premixed insulin, then match vial, cartridge, or pen format. Concentration alone does not establish identical composition, presentation, or total pack content.

Why Can Local Human Insulin 100 IU/mL Prices Differ From Global Benchmarks?

Cold delivery, device availability, national procurement programs, reimbursement rules, and local pharmacy charges influence the final bill. Pack sizes and included delivery devices also differ.